S&P Global Leads Strategic Investment in Kaiko, Extending Series B to $110 Million
14.9.2026 14:00:00 CEST | Business Wire | Press Release
Kaiko, the regulated provider of data services for onchain finance, today announced that S&P Global has led a strategic investment in the company, extending Kaiko's Series B to $110 million. S&P Global was joined in the round by additional strategic investors: BNP Paribas, Bpifrance, Broadridge, Canton Foundation, Coinbase Ventures, DRW Venture Capital, Nasdaq Ventures, Royal Bank of Canada, Stellar, and Susquehanna Private Equity Investments. Existing shareholders Anthemis, Point Nine, and Revaia, also participated in the extension.
The support of investors from across the financial ecosystem reflects a shift already underway: the institutions that run today's capital markets are now funding the data infrastructure required to operate tokenized markets. Alongside their investment, participating institutions have joined a Strategic Industry Working Group chaired by Kaiko, giving them a direct role in shaping the data and infrastructure used to bring tokenized products into production.
24/7 Market Infrastructure Requires 24/7 Data
Digital asset markets operate 24/7, and the infrastructure supporting them must do the same. Kaiko’s core business provides institutional-grade market data for digital assets. Its data infrastructure offering extends that foundation to onchain capital markets: delivering proprietary market data to smart contracts, transforming onchain financial activity into standardized off-chain data, and enabling confidential valuation and analytics.
As tokenization expands to Treasury bills, money market funds, equities, and bonds, this represents a natural extension of Kaiko’s established data business. The financing will strengthen both the core data business and the expanding data infrastructure offering.
"The investors in this strategic round work across the core functions of digital asset markets: pricing, trading, capital allocation, and blockchain development. They are backing both the company Kaiko has built, a regulated institutional-grade data provider covering over 150 exchanges and protocols, and our vision to provide the data infrastructure layer for onchain capital markets. These are partners, not just shareholders. Together we will define how institutional money moves onchain,” said Ambre Soubiran, CEO, Kaiko.
“As digital assets accelerate, S&P Global is investing for the future, and this investment underscores that conviction,” said Cathy Clay, CEO, S&P Dow Jones Indices. “Kaiko’s strength in crypto market data and analytics builds foundational transparency for the digital-asset ecosystem, turning complex trading and onchain activity into reliable, decision-ready intelligence. That capability supports our mission to advance essential intelligence by bridging traditional and decentralized finance, giving institutions the transparency and trust they need to deploy capital onchain with confidence.”
"We are pleased to participate in this investment round alongside a diverse group of financial institutions. As tokenized finance continues to evolve, the demand for robust market infrastructure, enhanced transparency, and trusted data will become paramount. We look forward to engaging in the industry dialogues led by Kaiko and supporting the continued evolution of this ecosystem," said Joe Bonnaud, Head of Global Markets EMEA at BNP Paribas.
Recent Milestones
Kaiko recently completed two major acquisitions: Cometh, a MiCA/CASP-regulated provider of DeFi infrastructure, and Amberdata, a digital asset market data provider and Kaiko’s former largest U.S. competitor. These two acquisitions, alongside the recent launch of the S&P Kaiko Digital Asset Indices suite and its ongoing data collaboration with Bloomberg, expand Kaiko’s U.S. footprint and its technical and regulatory capabilities.
This funding supports Kaiko's continued trajectory as the company builds out regulated data services for onchain finance.
Regulated Across Data and Digital Asset Services
Kaiko holds SOC 1 and SOC 2 Type 2 attestations from a Big Four audit firm. Kaiko Indices is authorized as a benchmark administrator under the EU Benchmark Regulation (EU-BMR), listed in the ESMA register of benchmark administrators, and Cometh is authorized by the AMF as a crypto-asset service provider (CASP) under the EU Markets in Crypto-Assets Regulation (MiCA). Kaiko also adheres to the IOSCO Principles for Financial Benchmarks.
About Kaiko
Kaiko provides regulated data services for onchain finance. Founded in 2014, the company delivers institutional-grade digital asset market data, analytics, indices, and data infrastructure for digital asset, tokenized, and traditional markets. Its clients include banks, asset managers, exchanges, and leading financial institutions worldwide. Kaiko's data and infrastructure support trading, valuation, risk management, tokenized assets, and onchain applications, connecting traditional and blockchain-based markets. For more information, visit www.kaiko.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260914036684/en/
Contacts
Media Contact
Victoria Calmon
press@kaiko.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex to Present New Data on ALYFTREK ® at the North American Cystic Fibrosis Conference9.10.2026 19:15:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children to discontinue pancreatic enzyme replacement therapy (PERT). Pancreatic exocrine insufficiency in children with cystic fibrosis (CF) was previously believed to be irreversible. These data were presented at the North American Cystic Fibrosis Conference (NACFC). “The data presented at NACFC underscore the safety and efficacy of our CF medicines in the real world and in clinical trials in younger age groups. The data from the Phase 3 open-label study in 2 to 5 year olds evaluating exocrine pancreatic function represent a profound shift in how we understand the benefits of treating cystic fibrosis in its earliest stages,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Devel
Verdant Rock Receives A (low) Financial Strength Rating from Morningstar DBRS, Adding a Second International Investment-Grade Assessment9.10.2026 16:00:00 CEST | Press Release
Verdant Rock Limited, a Bermuda Monetary Authority-regulated Class 3B insurance company, has received an A (low) Financial Strength Rating from Morningstar DBRS. The rating reflects Verdant Rock’s financial strength and its capacity to meet policyholder obligations as an investment-grade financial guarantor for Emerging Markets credit. Morningstar DBRS is a global credit rating agency with coverage across North America, Europe, Asia, and Latin America. Its assessment of Verdant Rock reflects the company’s strong projected earnings ability, robust risk profile, sound liquidity, and good capitalization. Morningstar DBRS also assigned an A (low) Issuer Rating to Verdant Rock. The rating follows Verdant Rock’s BBB+ Long-Term Insurer Financial Strength Rating with a Stable Outlook from Fitch Ratings, assigned on 12 June 2026. Verdant Rock now holds Financial Strength Ratings from both Fitch Ratings and Morningstar DBRS, providing counterparties with dual-agency confirmation of the company’s
Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions9.10.2026 15:17:00 CEST | Press Release
Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, today announced that Gartner has positioned it as a Visionary in the first-ever Magic Quadrant for AI-Enabled CSP Marketing and Sales Solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261009905430/en/ Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions A new category for a new operating model. CSPs are fighting saturated markets, rising acquisition costs, and accelerating churn. They are responding with AI-driven automation across the full revenue cycle, from segmentation and campaigns to lead management, CPQ, and renewals, increasingly executed by autonomous agents. According to us, Gartner creation of this Magic Quadrant confirms the shift has moved from pilot to boardroom priority. According to Gartner, Visionaries "understands where the market
Positive New Data on Corcym’s Perceval Plus Sutureless Aortic Heart Valve Encompasses up to 7-Year Follow-up9.10.2026 15:15:00 CEST | Press Release
Corcym, a global medical device company dedicated to cardiac surgery, today announced that positive mid-term data from a sub-analysis of its Perceval Plus sutureless aortic heart valve as part of its MANTRA clinical trial was featured in an oral presentation today at the annual meeting of the European Association for Cardio-Thoracic Surgery (EACTS). The study is the longest follow-up available for Perceval Plus and the FREE tissue treatment from an international multicenter study, and demonstrated excellent durability, safety and quality of life improvements. Perceval Plus is the only sutureless and collapsible aortic surgical heart valve. Its unique design performs in any surgical scenario and is optimal for endoscopy and robotics. The valve features the company’s FREE next generation tissue treatment addressing the two main causes of calcification, phospholipids and aldehydes. Its proprietary LANCELOT advanced manufacturing process includes zero-pressure shaping and laser cutting of
Ada earns AWS Travel and Hospitality Competency for resolving traveler issues at scale9.10.2026 15:00:00 CEST | Press Release
Ada, the pioneer in Agentic Customer Experience, today announced it has achieved the Amazon Web Services (AWS) Travel and Hospitality Competency. The designation recognizes Ada as an AWS Partner with demonstrated technical proficiency and proven customer success helping travel and hospitality brands resolve customer issues at scale. Ada joins a select group of 58 AWS Partners holding the competency, and it reflects a shared commitment to helping travel brands deliver service that holds up on their busiest, most unpredictable days. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261009673638/en/ Ada earns AWS Travel and Hospitality Competency for resolving traveler issues at scale "Travel is where agentic customer service gets tested hardest. Demand spikes without warning, policies change by the hour, and customers are often stressed and far from home," said Mike Murchison, CEO and co-founder of Ada. "Our airline and hospitali
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom